NL-OMON40401撤回2 期
Open, non-controlled, dose escalating Phase I trial to evaluate the pharmacokinetics, pharmacodynamics, tolerability, and toxicity of volasertib in paediatric patients from 2 years to less than 18 years of age with acute leukaemia or advanced solid tumour, for whom no effective treatment is known - volasertib in children
适应症
试验速览
- 阶段
- 2 期
- 状态
- 撤回
- 入组人数
- 2
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 至 17（—）
入选标准
- •children between age of 2 (included) and 17 (included)
- •relapsed/refractory acute leukemia after at least 2 previous intensive treatment regimens, or refractory first relapse
排除标准
- •eligibility for other anti-cancer therapy with curative intent
- •persistent relevant toxicity from previous therapy for the malignancy
- •anti-cancer treatment with other (investigational) drugs
- •relevant cardiovascular parameters (see protocol)
研究者
相似试验
进行中（未招募）
不适用
Open dose escalating trial to determine the maximum tolerated dose in paediatric patients with advanced leukaemia or solid tumoursEUCTR2013-001291-38-ITBoehringer Ingelheim60
进行中（未招募）
1 期
Open dose escalating trial to determine the maximum tolerated dose in paediatric patients with advanced leukaemia or solid tumoursMedDRA version: 17.1Level: LLTClassification code 10048683Term: Advanced cancerSystem Organ Class: 100000004864MedDRA version: 17.1Level: HLGTClassification code 10024324Term: LeukaemiasSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2013-001291-38-DEBoehringer Ingelheim Pharma GmbH & Co.KG60
进行中（未招募）
1 期
Open dose escalating trial to determine the maximum tolerated dose in paediatric patients with advanced leukaemia or solid tumoursMedDRA version: 17.1Level: LLTClassification code 10048683Term: Advanced cancerSystem Organ Class: 100000004864MedDRA version: 18.0Level: HLGTClassification code 10024324Term: LeukaemiasSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2013-001291-38-ATBoehringer Ingelheim RCV GmbH & Co KG40
进行中（未招募）
1 期
Open dose escalating trial to determine the maximum tolerated dose in paediatric patients with advanced leukaemia or solid tumoursMedDRA version: 17.0Level: LLTClassification code 10048683Term: Advanced cancerSystem Organ Class: 100000004864MedDRA version: 17.0Level: HLGTClassification code 10024324Term: LeukaemiasSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2013-001291-38-BESCS Boehringer Ingelheim Comm.V60
进行中（未招募）
1 期
Open dose escalating trial to determine the maximum tolerated dose in paediatric patients with advanced leukaemia or solid tumoursEUCTR2013-001291-38-FRBoehringer Ingelheim France40